1
|
Isaksson LJ, Mastroleo F, Vincini MG, Marvaso G, Zaffaroni M, Gola M, Mazzola GC, Bergamaschi L, Gaito S, Alongi F, Doyen J, Fossati P, Haustermans K, Høyer M, Langendijk JA, Matute R, Orlandi E, Schwarz M, Troost EGC, Vondracek V, La Torre D, Curigliano G, Petralia G, Orecchia R, Alterio D, Jereczek-Fossa BA. The emerging role of Artificial Intelligence in proton therapy: A review. Crit Rev Oncol Hematol 2024; 204:104485. [PMID: 39233128 DOI: 10.1016/j.critrevonc.2024.104485] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2024] [Accepted: 08/25/2024] [Indexed: 09/06/2024] Open
Abstract
Artificial intelligence (AI) has made a tremendous impact in the space of healthcare, and proton therapy is not an exception. Proton therapy has witnessed growing popularity in oncology over recent decades, and researchers are increasingly looking to develop AI and machine learning tools to aid in various steps of the treatment planning and delivery processes. This review delves into the emergent role of AI in proton therapy, evaluating its development, advantages, intended clinical contexts, and areas of application. Through the analysis of 76 studies, we aim to underscore the importance of AI applications in advancing proton therapy and to highlight their prospective influence on clinical practices.
Collapse
Affiliation(s)
- Lars Johannes Isaksson
- Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20141, Italy
| | - Federico Mastroleo
- Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20141, Italy
| | - Maria Giulia Vincini
- Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy.
| | - Giulia Marvaso
- Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20141, Italy.
| | - Mattia Zaffaroni
- Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy
| | - Michał Gola
- Department of Human Histology and Embryology, Collegium Medicum, School of Medicine, University of Warmia and Mazury, Olsztyn 10-082, Poland
| | - Giovanni Carlo Mazzola
- Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy
| | - Luca Bergamaschi
- Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy
| | - Simona Gaito
- Proton Clinical Outcomes Unit, The Christie NHS Proton Beam Therapy Centre, Manchester M20 4BX, UK; Division of Clinical Cancer Science, School of Medical Sciences, The University of Manchester Manchester M13 9PL, UK
| | - Filippo Alongi
- Department of Advanced Radiation Oncology, IRCCS Sacro Cuore Don Calabria, 37024 Negrar-Verona, Italy & DSMC, University of Brescia, Brescia, Italy
| | - Jerome Doyen
- Centre Antoine-Lacassagne, University of Côte d'Azur, Nice 06189, France; University Côte d'Azur, CNRS UMR 7284, INSERM U1081, Centre Antoine Lacassagne, Institute for Research on Cancer and Aging of Nice (IRCAN), 06189 Nice, France, Centre Antoine Lacassagne, Nice 06189, France
| | - Piero Fossati
- EBG MedAustron GmbH, Marie-Curie-Str. 5, Wiener Neustadt 2700, Austria; Department of General and Translational Oncology and Hematology, Karl Landsteiner University of Health Sciences, Krems an der Donau, 3500, Austria
| | - Karin Haustermans
- Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium
| | - Morten Høyer
- Aarhus University (AU), Nordre Ringgade 1, Aarhus C 8000, Denmark
| | - Johannes Albertus Langendijk
- Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
| | - Raùl Matute
- Centro de Protonterapia Quironsalud, Pozuelo de Alarcón, Madrid 28223, Spain
| | - Ester Orlandi
- Radiation Oncology Unit, Clinical Department, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy
| | - Marco Schwarz
- Radiation Oncology Department, University of Washington, Seattle, WA 98109, USA
| | - Esther G C Troost
- OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden 01309, Germany; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany, and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden 01307, Germany; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden 01309, Germany; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology-OncoRay, Dresden 01328, Germany
| | - Vladimir Vondracek
- Proton Therapy Centre Czech, Prague, Czech Republic and Department of Health Care Disciplines and Population Protection, Faculty of Biomedical Engineering, Czech Technical University Prague, Kladno, Czech Republic
| | - Davide La Torre
- Department of Oncology and Hemato-Oncology, University of Milan, Milan 20141, Italy; SKEMA Business School, Université Côte d'Azur, Sophia Antipolis, France
| | - Giuseppe Curigliano
- Department of Oncology and Hemato-Oncology, University of Milan, Milan 20141, Italy; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan 20141, Italy
| | - Giuseppe Petralia
- Department of Oncology and Hemato-Oncology, University of Milan, Milan 20141, Italy; Division of Radiology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy
| | - Roberto Orecchia
- Scientific Directorate, IEO European Institute of Oncology IRCCS, Milan 20141, Italy
| | - Daniela Alterio
- Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy
| | - Barbara Alicja Jereczek-Fossa
- Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan 20141, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20141, Italy
| |
Collapse
|
3
|
Malikov AKU, Flores Cuenca MF, Kim B, Cho Y, Kim YH. Ultrasonic tomography imaging enhancement approach based on deep convolutional neural networks. J Vis (Tokyo) 2023; 26:1-17. [PMID: 37360380 PMCID: PMC10230144 DOI: 10.1007/s12650-023-00922-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2022] [Revised: 03/06/2023] [Accepted: 04/01/2023] [Indexed: 06/28/2023]
Abstract
Abstract The containment liner plate (CLP) is a thin layer of carbon steel material applied as a base for concrete structures protecting nuclear material. The structural health monitoring of the CLP is critical to ensure the safety of nuclear power plants. Hidden defects in the CLP can be identified utilizing ultrasonic tomographic imaging techniques such as the reconstruction algorithm for the probabilistic inspection of damage (RAPID) methodology. However, Lamb waves have a multimodal dispersion feature, which makes the selection of a single mode more difficult. Thus, sensitivity analysis was utilized since it allows for the determination of each mode's level of sensitivity as a function of frequency; the S0 mode was chosen after examining the sensitivity. Even though proper Lamb wave mode was selected, the tomographic image had blurred zones. Blurring reduces the precision of an ultrasonic image and makes it more difficult to distinguish the dimensions of the flaw. To enhance the tomographic image of the CLP, deep learning architecture such as U-Net was utilized for the segmentation of the experimental ultrasonic tomographic image, which includes an encoder and decoder part for better visualization of the tomographic image. Nevertheless, collecting enough ultrasonic images to train the U-Net model was not economically feasible, and only a small number of the CLP specimens can be tested. Thus, it was necessary to utilize transfer learning and get the values of the parameters from a pre-trained model with a much larger dataset as a starting point for a new task, rather than training a new model from scratch. Through these deep learning approaches, we were able to eliminate the blurred section of the ultrasonic tomography, leading to images with clear edges of defects and no blurred zones. Graphical abstract
Collapse
Affiliation(s)
| | | | - Beomjin Kim
- Graduate School of Mechanical Engineering, Pusan National University, Busan, 46241 Korea
| | - Younho Cho
- School of Mechanical Engineering, Pusan National University, Busan, 46241 Korea
| | - Young H. Kim
- Institute of Nuclear Safety and Management, Pusan National University, Busan, 46241 Korea
| |
Collapse
|
5
|
Thariat J, Martel A, Matet A, Loria O, Kodjikian L, Nguyen AM, Rosier L, Herault J, Nahon-Estève S, Mathis T. Non-Cancer Effects following Ionizing Irradiation Involving the Eye and Orbit. Cancers (Basel) 2022; 14:cancers14051194. [PMID: 35267502 PMCID: PMC8909862 DOI: 10.3390/cancers14051194] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2022] [Revised: 02/14/2022] [Accepted: 02/24/2022] [Indexed: 12/04/2022] Open
Abstract
Simple Summary The irradiation of tumors involving the eye or orbit represents a complex therapeutic challenge due to the proximity between the tumor and organs that are susceptible to radiation. The challenges include tumor control, as it is often a surrogate for survival; organ (usually the eyeball) preservation; and the minimization of damage of sensitive tissues surrounding the tumor in order to preserve vision. Anticipation of the spectrum and severity of radiation-induced complications is crucial to the decision of which technique to use for a given tumor. The aim of the present review is to report the non-cancer effects that may occur following ionizing irradiation involving the eye and orbit and their specific patterns of toxicity for a given radiotherapy modality. The pros and cons of conventional and advanced forms of radiation techniques and their clinical implementation are provided with a clinical perspective. Abstract The eye is an exemplarily challenging organ to treat when considering ocular tumors. It is at the crossroads of several major aims in oncology: tumor control, organ preservation, and functional outcomes including vision and quality of life. The proximity between the tumor and organs that are susceptible to radiation damage explain these challenges. Given a high enough dose of radiation, virtually any cancer will be destroyed with radiotherapy. Yet, the doses inevitably absorbed by normal tissues may lead to complications, the likelihood of which increases with the radiation dose and volume of normal tissues irradiated. Precision radiotherapy allows personalized decision-making algorithms based on patient and tumor characteristics by exploiting the full knowledge of the physics, radiobiology, and the modifications made to the radiotherapy equipment to adapt to the various ocular tumors. Anticipation of the spectrum and severity of radiation-induced complications is crucial to the decision of which technique to use for a given tumor. Radiation can damage the lacrimal gland, eyelashes/eyelids, cornea, lens, macula/retina, optic nerves and chiasma, each having specific dose–response characteristics. The present review is a report of non-cancer effects that may occur following ionizing irradiation involving the eye and orbit and their specific patterns of toxicity for a given radiotherapy modality.
Collapse
Affiliation(s)
- Juliette Thariat
- Laboratoire de Physique Corpusculaire/IN2P3-CNRS UMR 6534—ARCHADE, Unicaen—Université de Normandie, 14000 Caen, France
- Correspondence: (J.T.); (T.M.)
| | - Arnaud Martel
- Service d’Ophtalmologie, Centre Hospitalier Universitaire de Nice, Université Côte d’Azur, 06000 Nice, France; (A.M.); (S.N.-E.)
- Laboratoire de Pathologie Clinique et Expérimentale, Biobank BB-0033-00025, Centre Hospitalier Universitaire de Nice, Université Côte d’Azur, 06000 Nice, France
| | - Alexandre Matet
- Service d’Oncologie Oculaire, Institut Curie, 75005 Paris, France;
| | - Olivier Loria
- Service d’Ophtalmologie, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, 69317 Lyon, France; (O.L.); (L.K.); (A.-M.N.)
| | - Laurent Kodjikian
- Service d’Ophtalmologie, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, 69317 Lyon, France; (O.L.); (L.K.); (A.-M.N.)
- UMR-CNRS 5510 Matéis, 69100 Villeurbanne, France
| | - Anh-Minh Nguyen
- Service d’Ophtalmologie, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, 69317 Lyon, France; (O.L.); (L.K.); (A.-M.N.)
| | - Laurence Rosier
- Centre Rétine Galien, Centre d’Exploration et de Traitement de la Rétine et de la Macula, 33000 Bordeaux, France;
| | - Joël Herault
- Service de Radiothérapie, Centre Antoine Lacassagne, 06000 Nice, France;
| | - Sacha Nahon-Estève
- Service d’Ophtalmologie, Centre Hospitalier Universitaire de Nice, Université Côte d’Azur, 06000 Nice, France; (A.M.); (S.N.-E.)
- INSERM, Biology and Pathologies of Melanocytes, Team1, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2019, Centre Méditerranéen de Médecine Moléculaire, 06200 Nice, France
| | - Thibaud Mathis
- Service d’Ophtalmologie, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, 69317 Lyon, France; (O.L.); (L.K.); (A.-M.N.)
- UMR-CNRS 5510 Matéis, 69100 Villeurbanne, France
- Correspondence: (J.T.); (T.M.)
| |
Collapse
|
6
|
Aust J, Mitrovic A, Pons D. Assessment of the Effect of Cleanliness on the Visual Inspection of Aircraft Engine Blades: An Eye Tracking Study. SENSORS (BASEL, SWITZERLAND) 2021; 21:6135. [PMID: 34577343 PMCID: PMC8473167 DOI: 10.3390/s21186135] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/18/2021] [Revised: 09/03/2021] [Accepted: 09/07/2021] [Indexed: 01/20/2023]
Abstract
Background-The visual inspection of aircraft parts such as engine blades is crucial to ensure safe aircraft operation. There is a need to understand the reliability of such inspections and the factors that affect the results. In this study, the factor 'cleanliness' was analysed among other factors. Method-Fifty industry practitioners of three expertise levels inspected 24 images of parts with a variety of defects in clean and dirty conditions, resulting in a total of N = 1200 observations. The data were analysed statistically to evaluate the relationships between cleanliness and inspection performance. Eye tracking was applied to understand the search strategies of different levels of expertise for various part conditions. Results-The results show an inspection accuracy of 86.8% and 66.8% for clean and dirty blades, respectively. The statistical analysis showed that cleanliness and defect type influenced the inspection accuracy, while expertise was surprisingly not a significant factor. In contrast, inspection time was affected by expertise along with other factors, including cleanliness, defect type and visual acuity. Eye tracking revealed that inspectors (experts) apply a more structured and systematic search with less fixations and revisits compared to other groups. Conclusions-Cleaning prior to inspection leads to better results. Eye tracking revealed that inspectors used an underlying search strategy characterised by edge detection and differentiation between surface deposits and other types of damage, which contributed to better performance.
Collapse
Affiliation(s)
- Jonas Aust
- Department of Mechanical Engineering, University of Canterbury, Christchurch 8041, New Zealand;
| | - Antonija Mitrovic
- Department of Computer Science and Software Engineering, University of Canterbury, Christchurch 8041, New Zealand;
| | - Dirk Pons
- Department of Mechanical Engineering, University of Canterbury, Christchurch 8041, New Zealand;
| |
Collapse
|